A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf
Conditions: Acute Graft Rejection; Diabetes
Interventions: Drug: Tacrolimus; Drug: Tacrolimus
Sponsors: University of British Columbia; Astellas Pharma Canada, Inc.
Recruiting - verified June 2016
Interventions: Drug: Tacrolimus; Drug: Tacrolimus
Sponsors: University of British Columbia; Astellas Pharma Canada, Inc.
Recruiting - verified June 2016